ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,798.40
      0.27%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      87.16
      0.87%
      Bitcoin
      66,129.92
      -1.09%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Protalix BioTherapeutics Inc (PLX)

      7. Protalix BioTherapeutics Inc (PLX) News

      PLX

      Protalix BioTherapeutics (PLX)

      Protalix BioTherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:PLX
      DateTimeSourceHeadlineSymbolCompany
      12:49PMiHub NewswireFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      01/02/20246:36AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
      12/26/20236:56AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      11/30/20234:00AMGlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
      11/06/20237:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
      11/06/20237:22AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      10/31/20234:40PMAllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
      10/20/20236:50AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      10/03/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      10/03/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      10/03/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      10/03/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      09/15/20234:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      09/15/20234:45PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      09/12/20236:58AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      09/06/20236:50AMPR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
      08/17/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      08/17/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      08/17/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      08/17/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
      08/11/20234:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
      08/07/20237:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
      08/07/20236:59AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      07/13/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      07/07/20234:30PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
      06/29/20237:25AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
      06/29/20237:24AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
      06/28/20234:30PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
      06/28/20234:30PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
      05/30/20237:24AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
       Showing the most relevant articles for your search:AMEX:PLX